Buys
Open market- Shares
- Avg price
- Total value
Hendrik Peter Scholl - Chief Medical Officer at BELITE BIO, INC
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- BLTE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Hendrik Peter Scholl in BELITE BIO, INC
Sells
Open market- Shares
- -20,500
- Avg price
- $143.45
- Total value
- -$2,940,824
Net
Past year- Shares
- -20,500
- Share %
- -100%
- Total value
- -$2,940,824
Reported holdings for Hendrik Peter Scholl in BELITE BIO, INC
Form 4 holding
Chief Medical Officer
BELITE BIO, INC
- Security class
- Ordinary Share
- Shares / value
- 35,000
- Estimated value
- $6,599,250
- Report date
- 18 Mar 2026
- Price
- $188.55
- Ownership
- By Bioptima Ltd.
Form 4 holding
Chief Medical Officer
BELITE BIO, INC
- Security class
- American depositary share
- Shares / value
- 14,500
- Estimated value
- $2,465,290
- Report date
- 01 Oct 2026
- Price
- $170.02
- Ownership
- By Bioptima Ltd.
Form 4 holding
Chief Medical Officer
BELITE BIO, INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 10,000
- Estimated value
- Report date
- 21 Apr 2026
- Price
- Ownership
- By Bioptima Ltd.
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Hendrik Peter Scholl in BELITE BIO, INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.